Xenon Pharmaceuticals (XENE) Short term Debt (2017 - 2020)

Xenon Pharmaceuticals (XENE) has 4 years of Short term Debt data on file, last reported at $15.7 million in Q1 2020.

• Short term Debt for Q1 2020 came in at $15.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2020 was $15.7 million (changed N/A YoY), and the FY2019 annual result was $4.6 million, changed N/A from the prior year.
• Short term Debt rose to $15.7 million in Q1 2020 per XENE's latest filing, from $4.6 million in the prior quarter.
• Over five years, Short term Debt peaked at $15.7 million in Q1 2020 and troughed at $700000.0 in Q4 2017.
• A 4-year average of $4.7 million and a median of $2.8 million in 2019 frame the typical range for Short term Debt.